Meissner
Private Company
Funding information not available
Overview
Meissner is a privately held, established provider of mission-critical filtration and single-use processing solutions for biopharmaceutical manufacturing. The company leverages deep scientific expertise, vertical integration, and a strong focus on automation and quality to serve as a strategic partner to drug developers and manufacturers. With a core value proposition centered on risk reduction and supply chain security, Meissner is positioned to benefit from the industry's continued shift toward single-use technologies and advanced bioprocessing. Its recent sustainability reporting and participation in major global trade shows indicate a mature, forward-looking organization.
Technology Platform
Comprehensive engineering and manufacturing platform for bioprocessing, including microfiltration (0.04-99 micron), single-use systems (SUS), specialized process platforms (e.g., CryoVault® freeze-thaw), and vertically integrated, automated manufacturing.
Opportunities
Risk Factors
Competitive Landscape
Meissner competes in the filtration and single-use systems market against major players like Merck KGaA (Millipore), Danaher (Cytiva), and Thermo Fisher Scientific, as well as other specialized firms such as Sartorius, Repligen, and Entegris. Its differentiation is based on deep vertical integration, a strong focus on personalized engineering services, and specialization in critical, high-value solutions rather than a broad commodity portfolio.